NDC 0023-5300

RHOFADE

Oxymetazoline Hydrochloride

RHOFADE is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Oxymetazoline Hydrochloride.

Product ID0023-5300_1acd8f72-9d36-4756-a3b0-3e354f12d7b2
NDC0023-5300
Product TypeHuman Prescription Drug
Proprietary NameRHOFADE
Generic NameOxymetazoline Hydrochloride
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2017-01-18
Marketing CategoryNDA / NDA
Application NumberNDA208552
Labeler NameAllergan, Inc.
Substance NameOXYMETAZOLINE HYDROCHLORIDE
Active Ingredient Strength10 mg/g
Pharm ClassesImidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0023-5300-30

1 TUBE in 1 CARTON (0023-5300-30) > 30 g in 1 TUBE
Marketing Start Date2017-01-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0023-5300-60 [00023530060]

RHOFADE CREAM
Marketing CategoryNDA
Application NumberNDA208552
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-01-18

NDC 0023-5300-30 [00023530030]

RHOFADE CREAM
Marketing CategoryNDA
Application NumberNDA208552
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2017-01-18

NDC 0023-5300-65 [00023530065]

RHOFADE CREAM
Marketing CategoryNDA
Application NumberNDA208552
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-10-01

NDC 0023-5300-35 [00023530035]

RHOFADE CREAM
Marketing CategoryNDA
Application NumberNDA208552
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-10-01

Drug Details

Active Ingredients

IngredientStrength
OXYMETAZOLINE HYDROCHLORIDE10 mg/g

OpenFDA Data

SPL SET ID:1ba1cc5b-4f7f-491b-a5af-a6a14fb5affd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1869821
  • 1869816

    • Pharmacological Class

    • Vasoconstrictor [EPC]
    • Vasoconstriction [PE]
    • Increased Sympathetic Activity [PE]
    • Imidazolines [CS]
    • Vasoconstrictor [EPC]
    • Vasoconstriction [PE]
    • Increased Sympathetic Activity [PE]
    • Imidazolines [CS]

    NDC Crossover Matching brand name "RHOFADE" or generic name "Oxymetazoline Hydrochloride"

    NDCBrand NameGeneric Name
    0023-5300RHOFADEOxymetazoline Hydrochloride
    71180-003RhofadeRhofade
    71403-003RhofadeRhofade
    10202-3047 Select Nasaloxymetazoline hydrochloride
    10202-8497 Select Original NasalOxymetazoline Hydrochloride
    11523-1159AfrinOxymetazoline hydrochloride
    11523-0073Afrin Allergy Sinus Nasaloxymetazoline hydrochloride
    11523-1160Afrin No Drip Nightoxymetazoline hydrochloride
    11523-0034Afrin NoDrip Allergy Sinus Nightoxymetazoline hydrochloride
    0363-0304Anefrin Nasaloxymetazoline hydrochloride
    0113-7388basic care nasalOxymetazoline Hydrochloride
    0113-7494basic care no drip nasalOxymetazoline hydrochloride
    11523-0091Children Afrin Extra Moisturizing Stuffy Nose Pump MistOxymetazoline hydrochloride
    11523-0090Children Afrin No Drip Extra Moisturizing Stuffy Nose Pump MistOxymetazoline hydrochloride
    0573-1191DRISTAN 12 HRoxymetazoline hydrochloride
    0113-0304Good Sense Nasaloxymetazoline hydrochloride
    0113-0817Good Sense Nasaloxymetazoline hydrochloride
    0113-2304Nasaloxymetazoline hydrochloride
    0904-5711NasalOxymetazoline Hydrochloride
    0536-5005Nasal ReliefOxymetazoline Hydrochloride
    0363-7007No Drip Anefrin NasalOXYMETAZOLINE HYDROCHLORIDE
    0363-2021Severe AnefrinOXYMETAZOLINE HYDROCHLORIDE
    0363-7009Severe Sinus Relief Mistoxymetazoline hydrochloride
    10237-464Zicam Extreme Congestion Reliefoxymetazoline hydrochloride
    10237-471Zicam Intense Sinus Reliefoxymetazoline hydrochloride

    Trademark Results [RHOFADE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RHOFADE
    RHOFADE
    86306966 5232934 Live/Registered
    EPI HEALTH, LLC
    2014-06-11
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.